SCHEMBL19106308

SCHEMBL19106308

c1ccc(-c2cc(-c3ccccc3)nc(-c3ccc(-c4nc(-c5ccccc5)nc5c4sc4ccccc45)cc3)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 10/20 0.45
▸ KMT2A Q03164 10/20 0.45
▸ ALDH1A1 P00352 7/20 0.45
▸ HPGD P15428 7/20 0.45
▸ MAPT P10636 6/20 0.45
▸ NTSR1 P30989 1/20 0.45
▸ KDM4E B2RXH2 4/20 0.40
▸ LMNA P02545 2/20 0.40
▸ ATM Q13315 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ ADORA2A P29274 2/20 0.40
▸ ADORA1 P30542 2/20 0.40
▸ TNKS O95271 2/20 0.39
▸ TNKS2 Q9H2K2 2/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ MAOA P21397 1/20 0.37
▸ MAOB P27338 1/20 0.37
▸ KRAS P01116 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19106211 1.00 MEN1 (0.45) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL19106214 0.94 MEN1 (0.42) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL19106357 0.94 MEN1 (0.39) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL19106283 0.94 CYP1A1 (0.40) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL19497504 0.94 MEN1 (0.43) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL19106356 0.94 MEN1 (0.39) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL18158349 0.93 MEN1 (0.42) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL18017854 0.93 MEN1 (0.45) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL18017848 0.93 MEN1 (0.45) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL18017759 0.93 MEN1 (0.45) MEN1KMT2AALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same DUK SAN NEOLUX CO., LTD (KR) 2020-08-04 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME NFE2L2, ESR1, VDAC2 MEN1 1003/4885KMT2A 581/4885ALDH1A1 1024/4885
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same NFE2L2, ESR1, VDAC2 MEN1 1003/4885KMT2A 581/4885ALDH1A1 1024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback